Dr Steineger is head of strategic innovation management in nutrition and health at BASF. She has served as vice president business development and vice president investor relations and communications at Pronova BioPharma (now part of BASF). Prior to this, she was senior associate with Neomed Management, an international investment firm focusing on the healthcare and life science industry. Dr Steineger has also been an independent adviser focusing on start-ups in the life science/healthcare sector and an equity analyst at Kreditkassen (now part of Nordea Markets) based in Oslo and Copenhagen. She began her professional career at Nycomed Pharma, where she worked in the area of clinical research and international marketing. Current board positions include Strongbridge Biopharma plc and PCI Biotech ASA. She holds a BSc and a PhD in medical biochemistry from the University of Oslo. She has served as a director in the company since November 2014. She is an independent director of the board.